Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Interest Expenses (2017 - 2023)

Kodiak Sciences' (KOD) quarterly Interest Expenses came in at $464.4 million in Q1 2026, up 24381.44% YoY from N/an in Q1 2025, and up 41.47% on a QoQ basis from $328.3 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Interest Expenses (2017 - 2023) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Interest Expenses data on file, last reported at $464.4 million in Q1 2026.

  • Quarterly Interest Expenses rose 24381.44% year-over-year to $464.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.4 million (up 24381.44% YoY) and the FY2025 annual result came in at $328.3 million, up 32.79% from the prior year.
  • Interest Expenses improved to $464.4 million in Q1 2026, from $328.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $464.4 million in Q1 2026 to a low of $4000.0 in Q4 2022.
  • A 5-year average of $59.7 million and a median of $5.0 million in 2023 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2022 — Interest Expenses tumbled 98.91% — and 2023, when it surged 378500.0%.
  • Tracing KOD's Interest Expenses over 5 years: stood at $4000.0 in 2022, then surged by 378500.0% to $15.1 million in 2023, then sank by 94.06% to $900000.0 in 2024, then soared by 36375.78% to $328.3 million in 2025, then soared by 41.47% to $464.4 million in 2026.
  • The last three Interest Expenses figures came in at $464.4 million (Q1 2026), $328.3 million (Q4 2025), and $166.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 5,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 4,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 5,000.00
Mar 31, 2022 5,000.00
Dec 31, 2021 30,000.00
Sep 30, 2021 6,000.00
Jun 30, 2021 5,000.00
Mar 31, 2021 6,000.00
Dec 31, 2020 6,000.00
Sep 30, 2020 6,000.00
Jun 30, 2020 6,000.00
Mar 31, 2020 7,000.00
Sep 30, 2019 2,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 4,000.00
Dec 31, 2018 190,000.00
Sep 30, 2018 1.98 Mn